Skip to content

Perioperative pain management in children and adolscents undergoing scoliosis surgery. Intravenous analgesia with S-Ketamine and Morphine versus epidural analgesia with Fentanyl-Bupivacaine-Epinephrine. Pain, nausea and psychological impact. - Scoliosis surgery pain

Perioperative pain management in children and adolscents undergoing scoliosis surgery. Intravenous analgesia with S-Ketamine and Morphine versus epidural analgesia with Fentanyl-Bupivacaine-Epinephrine. Pain, nausea and psychological impact. - Scoliosis surgery pain

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001642-19-SE
Enrollment
Unknown
Registered
2008-06-27
Start date
2008-12-01
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain management after scolios surgery on children/adolescents with idiopathic scoliosis MedDRA version: 9.1 Level: LLT Classification code 10036236 Term: Postoperative pain relief MedDRA version: 9.1 Level: LLT Classification code 10039727 Term: Scoliosis surgery

Interventions

Trade Name: Ketanest-S Product Name: Ketanest S Pharmaceutical Form: Intravenous infusion Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous d

Sponsors

Umeå University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consecutive children/adolscents scheduled for correctional surgery for idiopathic scoliosis. 12-18 years of age. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Any known hypersensitivty to any drug included in the study.

Design outcomes

Primary

MeasureTime frame
Main Objective: Compare two different modes of pain management concerning subjective pain measurment;Secondary Objective: Nausea, gastrointestinal function, a mount of and time to first rescue analgesia, global rating of patient satsifaction,pruritus, postopertive psychological impact. To improve saftey in pain management since epidural analgesia could involve serious side effects as infection and neurologic damage.;Primary end point(s): Pain at hospital and at home, intensity and duration, measured by VAS (0-100 mm)

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026